Nisa Investment Advisors
TBPH icon

Nisa Investment Advisors’s Theravance Biopharma TBPH Stock Holding History

Nisa Investment Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Buy
804
+124
+18% +$2.05K ﹤0.01% 2382
2026
Q1 		$11K Hold
680
– – ﹤0.01% 2212
2025
Q4 		$12.7K Buy
680
+497
+272% +$8.24K ﹤0.01% 2124
2025
Q3 		$2.67K Hold
183
– – ﹤0.01% 2560
2025
Q2 		$2.02K Hold
183
– – ﹤0.01% 2606
2025
Q1 		$1.63K Buy
183
+73
+66% +$679 ﹤0.01% 2520
2024
Q4 		$1.03K Hold
110
– – ﹤0.01% 2673
2024
Q3 		$887 Buy
110
+4
+4% +$35 ﹤0.01% 2607
2024
Q2 		$899 Sell
106
-16
-13% -$144 ﹤0.01% 2544
2024
Q1 		$1.09K Buy
122
+82
+205% +$760 ﹤0.01% 2351
2023
Q4 		$450 Hold
40
– – ﹤0.01% 2431
2023
Q3 		$345 Sell
40
-28
-41% -$270 ﹤0.01% 2593
2023
Q2 		$704 Hold
68
– – ﹤0.01% 2493
2023
Q1 		$1K Hold
68
– – ﹤0.01% 2458
2022
Q4 		$1K Hold
68
– – ﹤0.01% 2510
2022
Q3 		$1K Buy
+68
New +$637 ﹤0.01% 2511
2021
Q4 		– Sell
-7,000
Closed -$52K – 2320
2021
Q3 		$52K Buy
+7,000
New +$78.3K ﹤0.01% 1924
2021
Q2 		– Sell
-3,800
Closed -$78K – 2383
2021
Q1 		$78K Hold
3,800
– – ﹤0.01% 1860
2020
Q4 		$68K Buy
3,800
+113
+3% +$2.03K ﹤0.01% 1896
2020
Q3 		$55K Buy
3,687
+3,247
+738% +$60.8K ﹤0.01% 1767
2020
Q2 		$9K Sell
440
-4,810
-92% -$124K ﹤0.01% 1942
2020
Q1 		$121K Sell
5,250
-160
-3% -$4K ﹤0.01% 1324
2019
Q4 		$140K Sell
5,410
-3,090
-36% -$60K ﹤0.01% 1383
2019
Q3 		$166K Sell
8,500
-2,699
-24% -$54.5K ﹤0.01% 1367
2019
Q2 		$183K Hold
11,199
– – ﹤0.01% 1335
2019
Q1 		$254K Buy
+11,199
New +$284K ﹤0.01% 1245

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nisa Investment Advisors's TBPH Position: Q2 2026 in Review

Nisa Investment Advisors increased its Theravance Biopharma (TBPH) stake by 18% in Q2 2026, buying an estimated $2.05K and bringing the position to 804 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Nisa Investment Advisors first reported a position in TBPH in Q1 2019 and has held it in 26 quarters since. The position peaked at $254K in Q1 2019. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Nisa Investment Advisors held 804 shares of Theravance Biopharma worth $13.7K as of Q2 2026.
  • Nisa Investment Advisors bought 124 Theravance Biopharma shares in Q2 2026, an estimated $2.05K.
  • Theravance Biopharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2382 holding.
  • Nisa Investment Advisors first reported a position in Theravance Biopharma in Q1 2019 and has held it in 26 quarters since.
  • Nisa Investment Advisors's Theravance Biopharma position peaked at $254K in Q1 2019.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.